Development, Implementation and Evaluation of a Psychosocial Supportive Hope Focused Program for Patients With Advanced Cancer
60 Years
N/A
Both
Cancer
Trial Information
Development, Implementation and Evaluation of a Psychosocial Supportive Hope Focused Program for Patients With Advanced Cancer
The overall purpose of this study was to evaluate the effectiveness of a psychosocial
supportive intervention called “Living with Hope Program” (LWHP) in increasing hope and
quality of life for older adult community-living terminally ill cancer patients. Using a
mixed method concurrent nested experimental design, 60 terminally ill cancer patients over
the age of 60 years were randomly assigned to a treatment and control group. Baseline hope
[Herth Hope Index (HHI)] and quality of life scores [McGill Quality of Life Questionnaire,
(MQOL)] were collected at the first visit in the patients’ homes by trained research
assistants. Those in the treatment group received the LWHP, which consisted of viewing an
international award winning video on hope and a choice of one of three hope activities to
work on over a one-week period. The control group received standard care. Hope and quality
of life data were collected one week later from both groups. Qualitative data using
open-ended hope questions were collected from the treatment group.
Subjects receiving the Living with Hope Program had statistically significant higher hope
(U=255, p=.005) and quality of life scores at visit two (U=294.5, p=.027) than those in the
control group. Qualitative data confirmed this finding with the majority (61.5%) of subjects
in the treatment group reporting the LWHP increased their hope. This preliminary evaluation
of the effectiveness of the LWHP suggests that it may increase hope and quality of life for
older terminally ill cancer patients at home.
Inclusion Criteria:
Inclusion criteria for the study is; a) male or female 60 years of age and over, b)
diagnosed with cancer, c) receiving palliative home care services d) English speaking, e)
able to give informed consent and participate in the study as determined by the Palliative
Care Coordinator or SWADD team’s assessment.
Exclusion Criteria:
Exclusion criteria includes patients who are non-autonomous adults, cognitively impaired
as determined by the SWADD team and or unable in the opinion of the SWADD team to
participate-
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Hope (Herth Hope Index) and Quality of Life (MacGill Quality of Life Questionnaire.
Principal Investigator
Wendy Duggleby
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Saskatchewan
Authority:
Canada: Health Canada
Study ID:
BSC 03-899
NCT ID:
NCT00161317
Start Date:
December 2003
Completion Date:
February 2006
Related Keywords:
- Cancer
Name | Location |
|---|
